Domača stranFME • FRA
add
Fresenius Medical Care
Prejšnji trg. dan.
36,19 €
Dnevni razpon
36,32 € - 36,67 €
Letni razpon
30,92 € - 49,45 €
Tržna kapitalizacija
10,84 mrd. EUR
Povprečni obseg
302,00
Razm. P/E
22,25
Dividendna donosnost
3,25 %
Primarna borza
ETR
V novicah
Finančni podatki
Izkaz poslovnega izida
Prihodek
Čisti dohodek
| (EUR) | mar. 2024info | Sprememba L/L |
|---|---|---|
Prihodek | 4,72 mrd. | 0,43 % |
Stroški poslovanja | 812,17 mio. | −3,59 % |
Čisti dohodek | 70,96 mio. | −17,84 % |
Čista dobičkovnost prihodkov | 1,50 | −18,48 % |
Earnings per share | 0,64 | 77,95 % |
EBITDA | 873,92 mio. | 17,37 % |
Efektivna davčna stopnja | 25,03 % | — |
Bilanca stanja
Skupna sredstva
Skupne obveznosti
| (EUR) | mar. 2024info | Sprememba L/L |
|---|---|---|
Denar. in kratkor. naložbe | 1,15 mrd. | −6,18 % |
Skupna sredstva | 34,34 mrd. | −3,28 % |
Skupne obveznosti | 19,20 mrd. | −5,28 % |
Celoten lastniški kapital | 15,13 mrd. | — |
Shares outstanding | 293,41 mio. | — |
Razmerje P/B | 0,76 | — |
Donosnost sredstev | 2,65 % | — |
Donosnost kapitala | 3,34 % | — |
Denarni tok
Neto sprememba denarnih sredstev
| (EUR) | mar. 2024info | Sprememba L/L |
|---|---|---|
Čisti dohodek | 70,96 mio. | −17,84 % |
Denar iz dejavnosti | 127,31 mio. | −10,87 % |
Denar iz naložb | −68,37 mio. | 58,13 % |
Denar iz financiranja | −289,66 mio. | −14.482,17 % |
Neto sprememba denarnih sredstev | −235,23 mio. | −371,43 % |
Prost denarni tok | −318,80 mio. | −82,99 % |
Vizitka
Fresenius Medical Care AG & Co. KGaA is a German healthcare company which provides kidney dialysis services through a network of 4,171 outpatient dialysis centers, serving 345,425 patients. The company primarily treats end-stage renal disease, which requires patients to undergo dialysis 3 times per week for the rest of their lives.
With a global headquarters in Bad Homburg vor der Höhe, Germany, and a North American headquarters in Waltham, Massachusetts, it has a 38% market share of the dialysis market in the United States. It also operates 42 production sites, the largest of which are in the U.S., Germany, and Japan.
The company is 32% owned by Fresenius and, as of 2020, generates around 50% of the group's revenue.
The company is on the Best Employers List published by Forbes. Wikipedia
Generalni direktor
Datum ustanovitve
1996
Spletno mesto
Zaposleni
117.128
